Harish Chander

Dr. Harish Chander

National Institute of Biologicals
+1

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2018 in Cancer Chemotherapy and Pharmacology
Verified
Journal Article
Closed access
PDF file
ABAkshay Binayke
Akshay Binayke
SMSarthak Mishra
Sarthak Mishra
PSPrabhat Suman
Prabhat Suman
SDSuman Das
Suman Das
HCHarish Chander
Harish Chander

21 June 2022 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
VMVikrant Mehta
Vikrant Mehta
JMJaipal Meena
Jaipal Meena
HKHarit Kasana
Harit Kasana
AMAnjana Munshi
Anjana Munshi
HCHarish Chander
Harish Chander

12 April 2018 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
PSPrabhat Suman
Prabhat Suman
SMSarthak Mishra
Sarthak Mishra
HCHarish Chander
Harish Chander

5 August 2022 in Clinical and Translational Oncology
Verified
Journal Article
Closed access
PDF file
VMVikrant Mehta
Vikrant Mehta
PSPrabhat Suman
Prabhat Suman
HCHarish Chander
Harish Chander

9 December 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
SCSubhash Chand
Subhash Chand
VMVikrant Mehta
Vikrant Mehta
RSRatnesh K. Sharma
Ratnesh K. Sharma
AAAnupkumar R. Anvikar
Anupkumar R. Anvikar
HCHarish Chander
Harish Chander
Breast cancer remains the most commonly diagnosed cancer worldwide and exhibits a poor prognosis. The induction of genetic changes deregulates several genes that increase the disposal towards this life-threatening disease. CHAC2, a member of the glutathione degrading enzyme family has been shown to suppress gastric and colorectal cancer progression, however, the expression of CHAC2 in breast cancer has not been reported. We did an analysis of CHAC2 expression in breast cancer patients from various online tools like UALCAN, GEPIA2, GENT2, TIMER2, and bcGenExminer v4.8. Further, we used the Kaplan-Meier plotter to establish the significance of CHAC2 in BC patient survival and prognosis while TISIDB and TIMER databases were used to investigate the filtration of immune cells. The results showed that CHAC2 levels were high in breast cancer patients and elevated CHAC2 was associated with low overall survival. Taken together, the results of the present study show that like its paralog CHAC1, CHAC2 may also be an important biomarker and could have a potential therapeutic implication in breast cancer.

14 July 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
PSPrabhat Suman
Prabhat Suman
SMSarthak Mishra
Sarthak Mishra
HCHarish Chander
Harish Chander
Formin binding protein 17 (FBP17) belongs to Cdc-42 interacting protein 4 subfamily of F-BAR proteins. Recently, we had reported that FBP17 was overexpressed in invasive breast cancer cells and interacts with the actin regulatory proteins. We also reported that FBP17 promotes invadopodia formation and enhances extracellular matrix degradation. The current study determines FBP17 expression in invasive ductal carcinomas (IDCs) using breast cancer tissue microarrays (TMAs) (82 IDCs with variable receptor status and 8 Normal adjacent tissues) and its correlation with the clinico-pathological features. Immunohistochemistry of human breast cancer TMAs showed the significant elevation in the levels of FBP17 in breast cancer tissues than the normal (p ≤ 0.0001). Interestingly, FBP17 had a higher expression in invasive molecular subtypes HER2 and TNBC (p ≤ 0.05). Similarly, tumors with lymph node positive status showed elevated FBP17 expression in HER2 and TNBC subtypes (p ≤ 0.05). Surprisingly, grade 3 tumors demonstrated higher FBP17 expression (p ≤ 0.01) indicating its role in poorly differentiated tumors. Together, the data demonstrates the overexpression of FBP17 in invasive and poorly differentiated tumors. Understanding the role of FBP17 in poor differentiation and invasion of tumors in molecular subtypes at various level might represent as a potential molecular target against the disease.